SIGA Technologies Inc Sustainability Reports
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. It develops and commercializes antiviral solutions to treat biothreats and emerging infectious diseases, most notably its smallpox treatment TPOXX.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001S80PZ5
3 reports from 2005 to 2023